The event was attended by the dean of the faculty, Eduardo Magarelli, and the academic coordinator of the biotechnology programs, Carlos Sanguinetti, and the following startups were presented:
RADBIO: Development of innovative biopharmaceuticals and diagnostics for complex chronic diseases for which there is no cure or effective treatment/diagnosis. Led by Nicolás Tambucho, Engineer.
Hifa Biomaterials: Development of biomaterials derived from edible fungi and agro-industrial waste (rice husks, straw, sawdust, crop residues, and many others). In addition to being biodegradable, these materials offer the advantage of thermal insulation, sound absorption, flame retardancy, and partial hydrophobicity. Led by Engineer Felipe Machado.
Nanogrow: A biotechnology platform dedicated to providing dermatological solutions for both humans and pets. Unlike existing biopharmaceuticals on the market, which are administered systemically, Nanogrow develops biopharmaceuticals in cream form that can be applied directly to the affected area. Led by Mariana Ferrari, M.Sc.
Remotely activated nanodevices for cancer therapy: As a researcher in ORT’s Department of Biotechnology, Dr. Lorena Betancor presented a research project aimed at developing nanodevices for cancer therapy.
Recombinant protein expression with potential for use in tick vaccines: A partnership project with a biotechnology company aimed at developing a new veterinary vaccine. Led by Dr. Lorena Betancor, principal investigator at the Research and Innovation Center based at ORT.
Enteria: A startup dedicated to studying the gut microbiota as a tool for preventing and diagnosing diseases. Led by Pía Campot, B.S. in Engineering, MBA.